Differential Pharmacokinetics of Liver Tropism for Iron Sucrose, Ferric Carboxymaltose, and Iron Isomaltoside: A Clue to Their Safety for Dialysis Patients

Anemia is a major complication of end-stage kidney disease (ESKD). Erythropoiesis-stimulating agents and intravenous (IV) iron are the current backbone of anemia treatment in ESKD. Iron overload induced by IV iron is a potential clinical problem in dialysis patients. We compared the pharmacokinetics...

Descripción completa

Detalles Bibliográficos
Autores principales: Rostoker, Guy, Lepeytre, Fanny, Merzoug, Myriam, Griuncelli, Mireille, Loridon, Christelle, Boulahia, Ghada, Cohen, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323124/
https://www.ncbi.nlm.nih.gov/pubmed/35890303
http://dx.doi.org/10.3390/pharmaceutics14071408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323124/
https://www.ncbi.nlm.nih.gov/pubmed/35890303
http://dx.doi.org/10.3390/pharmaceutics14071408

Ejemplares similares